New Zealand markets closed

Biofrontera Inc. (BFRI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7200-0.0700 (-3.91%)
At close: 04:00PM EDT
1.7300 +0.01 (+0.58%)
After hours: 07:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.75M
Enterprise value 12.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.08
Price/book (mrq)1.83
Enterprise value/revenue 0.37
Enterprise value/EBITDA -0.69

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-85.08%
S&P500 52-week change 322.38%
52-week high 313.4200
52-week low 30.6100
50-day moving average 31.4681
200-day moving average 34.5539

Share statistics

Avg vol (3-month) 3649.02k
Avg vol (10-day) 359.3k
Shares outstanding 55.09M
Implied shares outstanding 65.3M
Float 82M
% held by insiders 128.19%
% held by institutions 139.21%
Shares short (15 Apr 2024) 443.98k
Short ratio (15 Apr 2024) 40.29
Short % of float (15 Apr 2024) 40.86%
Short % of shares outstanding (15 Apr 2024) 40.86%
Shares short (prior month 15 Mar 2024) 484.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 305 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -59.08%
Operating margin (ttm)-36.48%

Management effectiveness

Return on assets (ttm)-33.86%
Return on equity (ttm)-140.43%

Income statement

Revenue (ttm)34.07M
Revenue per share (ttm)22.03
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)N/A
EBITDA -20.85M
Net income avi to common (ttm)-20.13M
Diluted EPS (ttm)-13.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.42M
Total cash per share (mrq)0.28
Total debt (mrq)5.4M
Total debt/equity (mrq)112.64%
Current ratio (mrq)1.28
Book value per share (mrq)3.16

Cash flow statement

Operating cash flow (ttm)-24.89M
Levered free cash flow (ttm)-24.79M